David Black, Ph.D
Co-founder
Board of Directors, Member
Dr. Black founded 2nd Vote Inc., in 2012 in order to research and highlight corporate social justice activism. He is responsible for the overall strategy of the 2nd Vote family of companies. Dr. Black is a Fellow of the American Board of Forensic Toxicology (F-ABFT) and American Institute of Chemists (FAIC). He joined Vanderbilt University in 1986 as Assistant Professor in Pathology and Pharmacology and currently holds appointments in Pharmacology, Pathology, Microbiology and Immunology. In 1990 he founded Aegis Sciences Corporation where he served as Chairman and CEO until October of 2016. During his tenure, Dr. Black grew Aegis from 5 to over 1,000 employees as it became one of the largest drug testing companies in the nation. He has served as Program Administrator for substance abuse programs for NASCAR, IndyCar, WWE and as a consultant to MLBPA, NFL/NFLPA and to major corporations for development of their substance abuse prevention programs. He has testified in local, state, national and international courts as an expert witness regarding drug abuse. Dr. Black has authored numerous peer reviewed published scientific papers. He is also President of Ebon-Falcon, LLC (commercial real estate), and Founder and President of 2nd Vote Inc. (a 501c3 research organization monitoring corporate social activism). Dr. Black served in the U.S. Marine Corps (1966-70) and in combat in Vietnam (1968-69) and is a disabled veteran. Dr. Black earned his undergraduate degree from Loyola College in Baltimore and doctorate degree in Forensic Toxicology from the University of Maryland at Baltimore (1982).